Deutsche Bank AG Invests $14.99 Million in Novanta Inc. $NOVT

Key Points

• Deutsche Bank acquired 92,408 Novanta shares worth approximately $14.99 million in the second quarter, giving it a 0.24% stake. Institutional investors and hedge funds collectively own 98.35% of the company.
• Novanta exceeded quarterly expectations, reporting $0.89 in EPS versus the $0.83 consensus and $265.81 million in revenue, up 10.3% year over year. The company reaffirmed fiscal 2026 EPS guidance of $3.68–$3.74.
• Analyst sentiment is broadly positive, with upgrades from “Hold” to “Buy” and “Strong Buy”; Novanta carries a consensus “Buy” rating and a $194 average price target versus a recent price of $145.24.

Deutsche Bank AG purchased a new position in Novanta Inc. (NASDAQ:NOVT - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 92,408 shares of the technology company's stock, valued at approximately $14,992,000. Deutsche Bank AG owned approximately 0.24% of Novanta as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Harbor Investment Advisory LLC acquired a new stake in Novanta during the second quarter valued at approximately $54,000. Allworth Financial LP lifted its holdings in Novanta by 978.4% during the 4th quarter. Allworth Financial LP now owns 399 shares of the technology company's stock worth $47,000 after buying an additional 362 shares during the last quarter. Danske Bank A S bought a new position in Novanta during the 3rd quarter worth approximately $40,000. EverSource Wealth Advisors LLC grew its position in shares of Novanta by 120.1% in the 4th quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company's stock worth $51,000 after acquiring an additional 233 shares in the last quarter. Finally, ANTIPODES PARTNERS Ltd acquired a new position in shares of Novanta in the 4th quarter worth approximately $53,000. 98.35% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Matthijs Glastra sold 6,500 shares of the business's stock in a transaction that occurred on Thursday, July 2nd. The stock was sold at an average price of $161.13, for a total transaction of $1,047,345.00. Following the completion of the transaction, the chief executive officer owned 29,761 shares in the company, valued at $4,795,389.93. The trade was a 17.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.20% of the company's stock.

Novanta Price Performance

NOVT opened at $145.24 on Friday. The company has a quick ratio of 3.79, a current ratio of 4.57 and a debt-to-equity ratio of 0.12. The company's 50-day moving average price is $153.52 and its 200 day moving average price is $143.14. Novanta Inc. has a fifty-two week low of $98.27 and a fifty-two week high of $176.38. The firm has a market cap of $5.49 billion, a price-to-earnings ratio of 93.10 and a beta of 1.68.

Novanta (NASDAQ:NOVT - Get Free Report) last issued its earnings results on Wednesday, August 5th. The technology company reported $0.89 EPS for the quarter, beating analysts' consensus estimates of $0.83 by $0.06. The company had revenue of $265.81 million during the quarter, compared to the consensus estimate of $262.30 million. Novanta had a return on equity of 10.83% and a net margin of 6.00%.Novanta's quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.680-3.740 EPS and its Q3 2026 guidance at 0.950-1.000 EPS. As a group, sell-side analysts expect that Novanta Inc. will post 3.7 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Wall Street Zen raised Novanta from a "hold" rating to a "buy" rating in a research report on Sunday, August 9th. Robert W. Baird set a $194.00 price objective on Novanta in a research note on Friday, August 7th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Novanta in a report on Wednesday, July 15th. Finally, Zacks Research upgraded shares of Novanta from a "hold" rating to a "strong-buy" rating in a research note on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $194.00.

Novanta Company Profile

Novanta, Inc NASDAQ: NOVT is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta's product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta's Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source